Screening of therapeutics relies on representative cancer models. The representation of human glioblastoma by in vitro cell culture models is questionable. We obtained genomic profiles by array comparative genomic hybridization of both short-and long-term primary cell and spheroid cultures, derived from seven glioblastomas and one anaplastic oligodendroglioma. Chromosomal copy numbers were compared between cell cultures and spheroids and related to the parental gliomas using unsupervised hierarchical clustering and correlation coefficient. In seven out of eight short-term cell cultures, the genomic profiles clustered further apart from their parental tumors than spheroid cultures. In four out of eight samples, the genetic changes in cell culture were substantial. The average correlation coefficient between parental tumors and spheroid profiles was 0.89 (range: 0.79-0.97), whereas that between parental tumors and cell cultures was 0.62 (range: 0.10-0.96). In two out of three long-term cell cultures progressive genetic changes had developed, whereas the spheroid cultures were genetically stable. It is concluded that genomic profiles of primary cell cultures from glioblastoma are frequently deviant from parental tumor profiles, whereas spheroids are genetically more representative of the glioblastoma. This implies that glioma cell culture data have to be handled with the highest caution.
Screening of therapeutics relies on representative cancer models. The representation of human glioblastoma by in vitro cell culture models is questionable. We obtained genomic profiles by array comparative genomic hybridization of both short-and long-term primary cell and spheroid cultures, derived from seven glioblastomas and one anaplastic oligodendroglioma. Chromosomal copy numbers were compared between cell cultures and spheroids and related to the parental gliomas using unsupervised hierarchical clustering and correlation coefficient. In seven out of eight short-term cell cultures, the genomic profiles clustered further apart from their parental tumors than spheroid cultures. In four out of eight samples, the genetic changes in cell culture were substantial. The average correlation coefficient between parental tumors and spheroid profiles was 0.89 (range: 0.79-0.97), whereas that between parental tumors and cell cultures was 0.62 (range: 0.10-0.96). In two out of three long-term cell cultures progressive genetic changes had developed, whereas the spheroid cultures were genetically stable. It is concluded that genomic profiles of primary cell cultures from glioblastoma are frequently deviant from parental tumor profiles, whereas spheroids are genetically more representative of the glioblastoma. This implies that glioma cell culture data have to be handled with the highest caution. Keywords: glioma; primary cell culture; spheroid; comparative genomic hybridization; microarray Glioblastoma has a poor survival, despite maximal neurosurgical resection and chemoirradiation (Stupp et al., 2005) . In the development of new treatment modalities, biologically representative cancer models are essential. In vivo models appear to retain genetic hallmarks of human glioblastoma (Pandita et al., 2004) . However, therapeutic screening is limited to a low-throughput basis, whereas in vitro cancer models are suited for high-throughput screening of novel therapeutics. In vitro models include established cell line cultures, short-term primary cell cultures and organotypic spheroids. Often, the in vitro sensitivity of cancer cells does not correlate well with in vivo response. Especially, cell cultures have been long questioned to represent glioma biology due to changes under standard culture conditions (Wolff et al., 1999; Voskoglou-Nomikos et al., 2003; Lee et al., 2006) . Therefore, short-term primary cell cultures (with less than 10 trypsinization passages) and particularly three-dimensional spheroid models were considered to reflect the tumor biology better (Sutherland, 1988; Bjerkvig et al., 1990) . We hypothesized that spheroids more closely mirror the genetics of the primary tumors than primary cell cultures. Therefore, we compared the genomic profiles of short-term primary cell cultures, spheroid cultures and parental tumors of which cultures were derived. The genetic alterations in glioblastoma involved in gliomagenesis and progression are well characterized (Koschny et al., 2002; Kotliarov et al., 2006) . Notably, specific alterations correlate with response to therapy and prognosis in particular for oligodendroglioma (Cairncross et al., 1998; Burton et al., 2002) . To compare the genetic stability of primary cell cultures to those of spheroid cultures, copy number abnormalities were determined by genome-wide array comparative genomic hybridization (array CGH) (Snijders et al., 2001) . We found that profiles from a substantial number of short-term primary cell cultures had changed considerably compared to the parental tumor and that changes were progressive over weeks, whereas spheroid profiles were genetically stable.
Genomic profiles during short-term primary cell and spheroid culture As a first approach to determine similarities and differences in genetics, unsupervised clustering analysis was performed with 24 genomic profiles collected from eight parental tumor samples, their primary cell and spheroid cultures (Figure 1a ). Profiles derived from the same tissue material tended to cluster together, specifically those of samples 33, 32, 153, 60 and 58. In seven out of eight samples, the spheroid culture profile clustered closer to the parental tumor profile than the primary cell culture profile, with the exception of sample 58, where parental tumor, primary cell culture and spheroid culture had nearly identical profiles. The primary cell culture profiles of samples 3446, 160, 32 and 55 had altered substantially compared to the parental tumor profile. Notably, the primary cell cultures from samples 3446, 160 and 55 had reverted genome-wide to a near diploid status. This diploidy suggests contamination of primary cultures with normal cells, but the glial origin of cultured cells was confirmed by their GFAP positivity (primary antibody from Dako, Haverlee, Belgium; data not shown), indicating that glioma cells and not normal cells were cultured.
The copy numbers that changed in the primary cell culture profiles included genomic regions that are associated with therapeutic response and prognosis (Cairncross et al., 1998; Burton et al., 2002) . For instance, 1p loss as observed in the parental tumor of samples 3446 and 55 was reconstituted in the corresponding primary cell culture profiles. Furthermore, loss of chromosome 10 as observed in the parental tumor of samples 3446, 160 and 55 was reconstituted in the primary cell culture profiles. Amplification on 7p, the EGFR gene locus, as observed in the parental tumor samples 33 and 160, was lost in the short-term primary cell cultures.
Genomic profiles were in general well-preserved in short-term spheroid cultures (Figure 1a) , which is in contrast with profiles of short-term primary cell cultures. The average correlation coefficient between the whole-genomic primary cell culture and parental tumor profiles was 0.62 (range: 0.11-0.96) and between the whole-genomic spheroid culture and parental tumor profiles was 0.89 (range: 0.79-0.97) (Figure 1b) .
Genomic changes occur progressively in primary cell cultures, whereas spheroid cultures are genetically stable
To study the genetic stability of cell and spheroid cultures during an expanded period of time, we compared array CGH profiles from three patients after 2, 6 and 12 weeks in culture with the parental tumor samples as a reference (Figures 2a-c) . Primary cell culture profiles were preserved initially in samples 58 and 60. However, progressive changes occurred, most markedly at 12 weeks of culture (Figure 2d ). For instance, an initial 9p loss in the parental tumor of sample 55 became a 9p gain in primary cell culture at 12 weeks (Figure 2a) . A normal copy number of 2p and 11p in the parental tumor of sample 58 became a 2p and 11p gain in primary cell culture at 6 weeks and loss of the entire chromosome 2 and 11p occurred at 12 weeks ( Figure 2b) . A gain in chromosome 3 in the parental tumor of sample 60 was initially preserved in primary cell culture at 2 weeks and was lost at 12 weeks. Finally, an initial loss of 19q in the parental tumor of sample 60 was reconstituted at 12 weeks of primary cell culture (Figure 2c) .
The genomic profiles of spheroid cultures were stable up to 12 weeks of culture, resembling those of their parental tumors (Figure 2 ).
Array CGH confirms genetic alterations characteristic for glioblastoma
To validate the robustness of the array CGH technique, known genetic alterations were identified in the parental Figure 1 Comparison of genomic profiles of short-term primary cell and spheroid cultures derived from seven glioblastomas and one anaplastic oligodendroglioma. The clinical, histological and culture characteristics of the samples are shown in Supplementary Table  S1 . (a) Genomic profiles from the parental tumor (T, white), 2-week primary cell culture (C, yellow) and 2-week spheroid culture (S, blue) are displayed in cluster tree order. Data were obtained using an array comparative genomic hybridization (aCGH) with custom arrays containing 6.4K BAC clones, prepared as described (Smeets et al., 2006) . Therefore, BACs were spotted in triplicate onto CodeLink slides (Amersham Biosciences, Buckinghamshire, UK), using the OmniGrid 100 Microarrayer (Genomic Solutions, Ann Arbor, MI, USA) equipped with SMP3 pins (TeleChem, Sunnyvale, CA, USA). DNA was extracted from samples and peripheral blood from 18 male blood donors as reference using standard SDS-proteinase K methods and collected by ethanol precipitation. Labeling of extracted DNA with Cy3/Cy5 and hybridization to the arrays were performed as described (Smeets et al., 2006) . The array slides were scanned with Microarray Scanner G2505B (Agilent Technologies, Palo Alto, CA, USA), and the spot intensities were measured with BlueFuse (release 3.2; BlueGnome, Cambridge, UK; http://www.bluegnome.co.uk/). The data set was deposited at GEO (accession GSE6042) (Barrett et al., 2005) . For further analysis, spots were excluded with quality flag o1 or confidence value o0.85. Triplicates of spot ratios (Cy3/Cy5 intensity signals) were fused within BlueFuse in a confidence weighted fashion. The resulting log 2 transformed ratios were normalized to their mode value and shown as black dots. The gray reference lines represent À1 and þ 1 log 2 ratio values. Data are truncated at À1.4 and þ 1.4 (B0.1% of data points). The chromosomal positions of the BAC clones were retrieved from the UCSC genome browser (h16 freeze, 07/2003, NCBI built 34; http://genome.ucsc.edu/). Chromosomal numbering is printed above the data. After ordering the clones by chromosomal position, gains and losses for genomic regions were called with CGH plotter using default settings (release 7.1.2005; moving average filtering of 5 and a default constant value of 6) (Autio et al., 2003) . Outlined in red and green are estimated copy number gains and losses, respectively, of genomic regions according to the CGH-plotter method. The ordered whole-genome profiles with data points that retain the amplitude of genomic changes as called by CGH-plotter were hierarchically clustered using Pearson's uncentered correlation coefficient as metric with average linking in Cluster (release 3.0), based on an algorithm as described (Eisen et al., 1998) and plotted in TreeView (release 1.0.12). Qualitatively similar results were obtained when the correlation coefficients were calculated by Kendall's t or Spearman's r statistics (data not shown). The chromosomes X and Y were omitted from the cluster analysis, because the intensity ratios were considered noninformative regarding cancer-related copy number abnormalities. Nodes in the cluster tree to the right increase in similarity of genomic profiles from right to left. (b) Bar chart comparing similarity of genomic profiles for primary cell culture and parental tumor (yellow), and spheroid culture and parental tumor (blue) of each of the eight samples, expressed as Pearson's correlation coefficients using the R package (release 2.2.1; http://cran.r-project.org/). glioma samples. Several specific genetic alterations have been observed in human glioblastoma, including losses of 9p21 (CDKN2A), 10q23 (PTEN) and 13q14 (Rb), and gains of 1q32 (MDM4), 7p12 (EGFR), 8q24 (c-MYC) and 12q13-15 (CDK4); and in oligodendroglioma, loss of 1p and 19q (Koschny et al., 2002) . The frequency of involvement of copy number changes in the present analysis with relatively few samples was consistent with this. In our study, loss of 9p21 was observed in five out of eight samples, loss of chromosome 10 in all samples, four of which included apparent homozygote losses (log 2 ratiooÀ0.8) of PTEN at 10q23 and loss of 13q14 in three out of eight samples. Furthermore, gain of 1q32 was observed in two samples, gain of chromosome 7 in four samples, two of which were apparent EGFR amplifications (log 2 ratio>3) at 7p12, gain of 8q24 in one sample and gain of 12q13-15 in one sample.
Experimental modeling of glioblastoma
Evident advantages of two-dimensional monolayer cell systems for experimental studies are ease of culture, low expense and prompt and reproducible results on a large scale. Crucial, however, for studies involving therapeutic screening is whether tumor biology is adequately portrayed by this model system. Recently, significant genomic rearrangements in early passages (up to p10) of primary cell culture were reported based on single nucleotide polymorphism analysis in one glioblastoma sample (Lee et al., 2006) . In the present study, we demonstrate genetic discordance between the parental tumor and derived primary cell cultures to be frequent and to appear early, already after 2 weeks of culture. Therefore, primary cell cultures inappropriately reflect glioblastoma genetically. Although we provide no direct evidence that the genetic discordance results in altered therapeutic responses, it emphasizes the invalid representation of tumor biology by primary cell cultures. This was also shown by alterations in ploidy status of glioma cell cultures at later passages (Bigner et al., 1987) . In contrast, several studies report concordant cytogenetics in cell culture and parental tissue (Izumoto et al., 1995; Hartmann et al., 1999) . We suspect that the discrepancy with our current study is a result of either the low resolution of techniques such as ploidy analysis and karyotyping or the limited number of target genes. The organotypic spheroid model appears to be more suitable for therapeutic screening on a large scale, since genetic alterations are better preserved.
There are several potential explanations for the preservation of genomic profiles in spheroids and the progressive genetic changes in primary cell cultures. First, subpopulations may have been selected during primary cell culture, due to culture conditions and technical procedures, such as trypsinization, the serum type or the affinity for plastic. The existence of cell subpopulations is supported by considerable genetic heterogeneity observed within glioblastomas and glioma cell cultures (Hartmann et al., 1999; Steilen-Gimbel et al., 1999; Loeper et al., 2001) . Second, the divergent clonal evolution may have been accelerated during primary cell culture, because cell proliferation is more pronounced in monolayer cell cultures than in spheroid cultures. Third, the clonal evolution may be more divergent in primary cell culture, because the progenitor cells or tumor stem cells that presumably drive the cancer cell population were possibly lost early in primary cell culture and maintained in spheroid culture. This assumption is supported by preliminary data showing stem cell marker (CD133)-positive immunostaining in frozen sections of spheroids after long-term culture (data not shown). However, the continuing debate on cancer stem cell detection in glioma precludes convincing proof of this assumption. Selection of subpopulations at initiation of culture due to microheterogeneity in the original tumor sample is not a very likely explanation, because fragments of tumors used for primary cell and spheroid cultures were carefully homogenized. The exact nature of the genetic instability of cells in culture is not known, but it casts doubt on the representation of glioblastoma biology by cultured glioma cells.
In summary, the present study demonstrates genomic profiles of primary cell cultures that are deviant from their parental tumors within the limitations of array CGH analysis. Characteristic genetic abnormalities are preserved in organotypic spheroid cultures until at least 12 weeks. Therefore, spheroids are genetically a more representative model for human glioblastoma. These observations imply that the relevance of primary cell cultures for therapeutic screening studies, even after short-term culture, should be seriously questioned.
